During 48 weeks of treatment, the efficacy was assessed by the Yale Global Tie Severity Scale (YGTSS) and the safety were evaluated by Treatment Emergent Symptom Scale (TESS).

• 研究组又分为幼儿组(17例)、年长儿组(23例)及按发作形式分为肢体抽动组(13例)、头面部抽动组(19例)和混合组(8例)。 对研究对象于治疗前与治疗中(4、8、24、48周)进行耶鲁抽动症整体严重度量表(YGTSS)和不良反应量表(TESS)评估。